Source comparison
Comparison of CJC 1295 vs Sermorelin
CJC 1295 Sermorelin Structure Peptide analog of growth hormone-releasing hormone (GHRH) with a modified structure for increased stability Peptide analog of GHRH with a structure that closely resembles the natural hormone. Weight Approximately 3647.15 g/mol. Ap
This comparison does not assign a generated winner or score.
- CJC 1295
- Sermorelin
- Structure
- Peptide analog of growth hormone-releasing hormone (GHRH) with a modified structure for increased stability
- Peptide analog of GHRH with a structure that closely resembles the natural hormone.
- Weight
- Approximately 3647.15 g/mol.
- Approximately 3357.88 g/mol.
- Mechanism
- Stimulates the release of growth hormone (GH) from the pituitary gland by binding to and activating the GHRH receptor.
- Acts on the pituitary gland to stimulate the release of growth hormone in a pulsatile and physiologically similar manner to the body’s natural GHRH.
- Function
- Can promote muscle growth, fat loss, and overall vitality by increasing GH levels.
- Increases growth hormone levels, potentially improving muscle mass, fat metabolism, and overall well-being.
- Side Effects
- Injection site reactions, water retention, and changes in insulin sensitivity.
- Includes injection site reactions, headaches, and flushing. It tends to have fewer side effects compared to CJC 1295.
- Regulatory Status
- Not approved for medical use by the FDA and is generally considered a research chemical.
- FDA-approved for the diagnosis and treatment of growth hormone deficiency in children [3] but is not approved for anti-aging or athletic enhancement purposes in adults.
- Peptide Functions – The Difference Between CJC 1295 and Sermorelin